Summary
Insulin resistance and impaired insulin secretion are thought to be the primary defects in the pathogenesis of non-insulin-dependent diabetes mellitus (NIDDM). Disproportionately increased proinsulin relative to insulin levels are suggested to be an early indicator of a failing pancreas. We examined the relationship of fasting specific insulin, proinsulin, and 32, 33 split proinsulin concentrations, and the proinsulin: insulin ratio to the risk of developing NIDDM 3.5 years later in 65–74-year-old non-diabetic Finnish subjects participating in a populationbased study (n=892) on diabetes and heart disease. Altogether 69 subjects developed NIDDM over a 3.5-year follow-up (cases). The cases were compared to randomly-selected gender-matched control subjects (n=69) and control subjects matched for gender, glucose tolerance status (normal or impaired), and body mass index (n=69). There were no differences in insulin concentrations between cases and random or matched control subjects [median and interquartile range; 123 (77–154), 108 (74–143), 118 (83–145) pmol/l, p=0.271]. Random control subjects had lower proinsulin and 32,33 split proinsulin concentrations and split proinsulin: insulin ratios compared to cases [5.7 (3.8–9.0) vs 7.3 (4.8–10.0) pmol/l, p=0.005; 7.3 (4.5–13.0) vs 10.4 (7.1–18.0) pmol/l, p=0.002; 0.073 (0.057–0.110) vs 0.097 (0.060–0.135), p=0.003]. Matched control subjects had lower proinsulin concentrations and proinsulin: insulin ratios compared to cases [5.9 (4.0–7.7) vs 7.3 (4.8–10.0) pmol/l, p=0.019; 0.048 (0.035–0.071) vs 0.064 (0.045–0.100), p=0.008]. When cases were compared to matched control subjects a 1 SD increase in baseline proinsulin: insulin ratio was associated with a 1.37-fold risk (p=0.020) of developing diabetes. Moreover, this association was independent of fasting glucose concentration at baseline. Thus, in elderly prediabetic subjects disproportionately increased proinsulin concentration, an indicator of defective insulin secretion, is associated with conversion to diabetes over a short time period.
Article PDF
Similar content being viewed by others
Abbreviations
- NIDDM:
-
Non-insulin-dependent diabetes mellitus
- IRI:
-
immunoreactive insulin
- OR:
-
odds ratio
- CI:
-
confidence interval
References
Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH (1989) Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes. Lancet I: 1356–1359
Sicree RA, Zimmet PZ, King HOM, Coventry JS (1987) Plasma insulin response among Nauruans. Prediction of deterioration in glucose tolerance over 6 yr. Diabetes 36: 179–186
Haffner SM, Stern MP, Mitchell BD, Hazuda HP, Patterson JK (1990) Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution. Diabetes 39: 283–288
Charles MA, Fontbonne A, Thibult N, Warnet J-M, Rosselin GE, Eschwege E (1991) Risk factors for NIDDM in white population: Paris Prospective Study. Diabetes 40: 796–799
Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C, Groop L (1989) Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321: 337–343
Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR (1990) Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 113: 909–915
Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Charles MA, Bennett PH (1991) A two-step model for development of non-insulin-dependent diabetes. Am J Med 90: 229–235
Lillioja S, Mott DM, Spraul M et al. (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 329: 1988–1992
Luft R, Wajngot A, Efendic S (1981) On the pathogenesis of maturity-onset diabetes. Diabetes Care 4: 58–63
O'Rahilly SP, Nugent Z, Rudenski AS, Hosker JP, Burnett MA, Darling P, Turner RC (1986) Beta-cell dysfunction, rather than insulin insensitivity, is the primary defect in familial type 2 Diabetes. Lancet II: 360–364
Arner P, Pollare T, Lithell H (1991) Different aetiologies of type 2 (non-insulin-dependent) diabetes mellitus in obese and non-obese subjects. Diabetologia 34: 483–487
Porte D, Kahn SE (1989) Hyperproinsulinemia and amyloid in NIDDM. Clues to etiology of islet Β-cell dysfunction? Diabetes 38: 1333–1336
Ward WK, LaCava EC, Paquette TL, Beard JC, Wallum BJ, Porte Jr. D (1987) Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin-resistance. Diabetologia 30: 698–702
Temple RC, Carrington CA, Luzio SD, Owens DR, Schneider AE, Sobey WJ, Hales CN (1989) Insulin deficiency in non-insulin-dependent diabetes. Lancet I: 293–295
Saad MF, Kahn SE, Nelson RG et al. (1990) Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 70: 1247–1253
Clark PM, Levy JC, Cox L, Burnett M, Turner RC, Hales CN (1992) Immunoradiometric assay of insulin, intact proinsulin and 32, 33 split proinsulin and radioimmunoassay of insulin in diet-treated type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 35: 469–474
Davis SN, Piatti PM, Monti L, Brown MD, Branch W, Hales CN, Alberti KGMM (1993) Proinsulin and insulin concentrations following intravenous glucose challenge in normal, obese, and non-insulin-dependent diabetic subjects. Metabolism 42: 30–35
Yoshioka N, Kuzuya T, Matsuda A, Taniguchi M, Iwamoto Y (1988) Serum proinsulin levels at fasting and after oral glucose load in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 31: 355–360
Williams DRR, Byrne C, Clark PMS (1991) Raised proinsulin concentration as early indicator of Β-cell dysfunction. BMI 303: 95–96
Reaven GM, Chen Y-DI, Hollenbeck CB, Sheu WHH, Ostrega D, Polonsky KS (1993) Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance. J Clin Endocrinol Metab 76: 44–48
Davies MJ, Rayman G, Gray IP, Day IL, Hales CN (1993) Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance. Diabet Med 10: 313–320
Shiraishi I, Iwamoto Y, Kuzuya T, Matsuda A, Kumakura S (1991) Hyperinsulinaemia in obesity is not accompanied by an increase in serum proinsulin/insulin ratio in groups of human subjects with and without glucose intolerance. Diabetologia 34: 737–741
MykkÄnen L, Laakso M, Uusitupa M, PyörÄlÄ K (1990) Prevalence of diabetes and impaired glucose tolerance in elderly subjects and their association with obesity and family history of diabetes. Diabetes Care 13: 1099–1105
MykkÄnen L, Laakso M, PenttilÄ I, PyörÄlÄ K (1991) Asymptomatic hyperglycemia and cardiovascular risk factors in the elderly. Atherosclerosis 88: 153–161
MykkÄnen L, Kuusisto J, PyörÄlÄ K, Laakso M (1993) Cardiovascular disease risk factors as predictors of type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects. Diabetologia 36: 553–559
World Health Organization (1985) Diabetes mellitus. Report of a WHO Study Group. (Technical Report Series No. 727). World Health Organization, Geneva
Hales CN, Randle PJ (1963) Immunoassay of insulin with insulin antibody precipitate. Biochem J 88: 137–146
Sobey WJ, Beer SF, Carrington CA et al. (1989) Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65–66 split and 32–33 split proinsulins. Biochem J 260: 535–541
Gulli G, Ferrannini E, Stern M, Haffner S, DeFronzo RA (1992) The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes 41: 1575–1586
Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH (1988) The natural history of impaired glucose tolerance in the Pima Indians. N Engl J Med 319: 1500–1506
Koivisto VA, Yki-JÄrvinen H, Hartling SG, Pelkonen R (1986) The effect of exogenous hyperinsulinemia on proinsulin secretion in normal man, obese subjects, and patients with insulinoma. J Clin Endocrinol Metab 63: 1117–1120
Bergenstal RM, Cohen RM, Lever E et al. (1984) The metabolic effects of biosynthetic human proinsulin in individuals with type 1 diabetes. J Clin Endocrinol Metab 58: 973–979
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
MykkÄnen, L., Haffner, S.M., Kuusisto, J. et al. Serum proinsulin levels are disproportionately increased in elderly prediabetic subjects. Diabetologia 38, 1176–1182 (1995). https://doi.org/10.1007/BF00422366
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00422366